BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
IGF1
,
calcium channel activity
,
Pseudomonas infection
,
Adipose tissue
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
haematology
Summary
General Info
Curated Studies
Most Correlated Studies
B-cell lymphoma TMD8 and DOHH-2 cells after oral pan-histone deacetylase inhibitor treatment
Transient myeloproliferative disorder (TMD) + acute megakaryoblastic leukaemia (AMKL) in DS patients
Erythroid progenitor cells cultured from blood of beta-thalassaemia patients
RUNX1-RUNX1T1 mutation during myeloid and erythroid development
Mesenchymal cells and the effects of culture conditions
Explore Curated Studies Results
Literature
Most Relevant Literature
Secondary haematological malignancies.
Burnout in the haematological workforce.
Thank you to The Lancet Haematology's peer reviewers in 2022.
Haematology in times of planetary instability.
Increasing availability of oral therapy in haematology.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors
Economic Evaluation of Innovative Molecular Analyses in Onco-haematology
Covid-19 Vaccine Response in Immunocompromised Haematology Patients
MethylphenIdate for Fatigue in Haematological Cancer
Study on Patient Blood Management in Haematological Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ